{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T21:48:25Z","timestamp":1722721705474},"reference-count":42,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T00:00:00Z","timestamp":1555804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"publisher","award":["114\/16"],"award-info":[{"award-number":["114\/16"]}],"id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Retrograde lung vascular perfusion can appear in high\u2010risk surgeries. The present report is the first to study long\u2010term retrograde perfusion of isolated perfused mouse lungs (IPLs) and to use the tyrosine kinase ephB4 and its ligand ephrinB2 as potential markers for acute lung injury. Mouse lungs were subjected to anterograde or retrograde perfusion with normal\u2010pressure ventilation (NV) or high\u2010pressure ventilation (=overventilation, OV) for 4\u00a0hours. Outcome parameters were cytokine, ephrinB2 and ephB4 levels in perfusate samples and bronchoalveolar lavage (BAL), and the wet\u2010to\u2010dry ratio. Anterograde perfusion was feasible for 4\u00a0hours, while lungs receiving retrograde perfusion presented considerable collapse rates. Retrograde perfusion resulted in an increased wet\u2010to\u2010dry ratio when combined with high\u2010pressure ventilation; other physiological parameters were not affected. Cytokine levels in BAL and perfusate, as well as levels of soluble ephB4 in BAL were increased in OV, while soluble ephrinB2 BAL levels were increased in retrograde perfusion. BAL levels of ephrinB2 and ephB4 were also determined in vivo, including mice ventilated for 7\u00a0hours with normal\u2010volume ventilation (NVV) or high\u2010volume ventilation (HVV) with increased levels of ephB4 in HVV BAL compared to NVV. Retrograde perfusion in IPL is limited as a routine method to investigate effects due to collapse for yet unclear reasons. If successful, retrograde perfusion has an influence on pulmonary oedema formation. In BAL, ephrinB2 seems to be up\u2010regulated by flow reversal, while ephB4 is a marker for acute lung injury.<\/jats:p>","DOI":"10.1111\/bcpt.13236","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T17:04:25Z","timestamp":1553879065000},"page":"279-288","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Retrograde perfusion in isolated perfused mouse lungs\u2014Feasibility and effects on cytokine levels and pulmonary oedema formation"],"prefix":"10.1111","volume":"125","author":[{"given":"Julia","family":"Krabbe","sequence":"first","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"},{"name":"Medical Faculty Institute of Occupational, Social and Environmental Medicine, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Ruske","sequence":"additional","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Kanzler","sequence":"additional","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy Kathleen","family":"Reiss","sequence":"additional","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Uhlig","sequence":"additional","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Martin","sequence":"additional","affiliation":[{"name":"Medical Faculty Institute of Pharmacology and Toxicology, RWTH Aachen University Aachen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,4,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.184937"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.113.301826"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.06720.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000216595.15868.55"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02522869"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(02)00039-9"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205948200"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1242\/bio.20134622"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/ten.tea.2011.0514"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1117810109"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.12.003"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2006.05.048"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00201.2017"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/dvdy.24252"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1973910"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-386503-8.00002-8"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2000.9957"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2000.0112"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-7580.2003.00137.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.4161\/19336918.2014.970026"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1302553110"},{"key":"e_1_2_8_23_1","unstructured":"LagaresD Ghassemi\u2010KakroodiP TremblayC BaronM BlatiM ZhanY.Fibroblast\u2010Derived Ephrin\u2010B2 regulates lung fibrosis in vivo by promoting fibroblast recruitment and myofibroblast differentiation. In: A29 NEW KIDS ON THE FIBROTIC BLOCK: LUNG FIBROSIS AND FIBROBLAST BIOLOGY [Internet]. American Thoracic Society; 2014. S. A1242\u2013A1242. (American Thoracic Society International Conference Abstracts).http:\/\/www.atsjournals.org\/doi\/abs\/10.1164\/ajrccm-conference.2014.189.1_MeetingAbstracts.A1242. Accessed November 26 2015"},{"key":"e_1_2_8_24_1","unstructured":"MontesiS PardoA SelmanM SheaB TagerA LagaresD.Soluble Ephrin\u2010B2 is a Novel Biomarker for Idiopathic Pulmonary Fibrosis \u2010 ajrccm\u2010conference.2015.191.1_MeetingAbstracts.A4374.2015.http:\/\/www.atsjournals.org\/doi\/pdf\/10.1164\/ajrccm-conference.2015.191.1_MeetingAbstracts.A4374. Accessed January 7 2016"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4419"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13059"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702394"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23513-0"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024527"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041464"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00187.2003"},{"issue":"6","key":"e_1_2_8_32_1","first-page":"H1865","article-title":"cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i","volume":"274","author":"He P","year":"1998","journal-title":"Am J Physiol."},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.76.2.199"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00598-1"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2007.09.001"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00975.2011"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.311045"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2015.10.009"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.05.071"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.177907"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02015293"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2012.08.001"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i29.8894"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.13236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcpt.13236","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcpt.13236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T22:24:42Z","timestamp":1694211882000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bcpt.13236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,21]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1111\/bcpt.13236"],"URL":"https:\/\/doi.org\/10.1111\/bcpt.13236","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,21]]},"assertion":[{"value":"2018-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}